Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
about
Tamoxifen Resistance: Emerging Molecular TargetsIdentification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβThe effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeletonPredictive features of ligand-specific signaling through the estrogen receptorRegioselective synthesis and biological studies of novel 1-aryl-3, 5-bis (het) aryl pyrazole derivatives as potential antiproliferative agents.Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?Development of subtype-selective oestrogen receptor-based therapeutics.Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats.ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerPharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancerClinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen.Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials.Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G.Estrogen receptor-beta and breast cancer: translating biology into clinical practiceERβ expression and breast cancer risk prediction for women with atypias.Involvement of estrogen receptor β5 in the progression of glioma.Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody.Sex hormone receptor repertoire in breast cancer.Estrogen receptor β isoform 5 confers sensitivity of breast cancer cell lines to chemotherapeutic agent-induced apoptosis through interaction with Bcl2L12.Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cellsCan predictive biomarkers in breast cancer guide adjuvant endocrine therapy?Steroid hormone receptors as prognostic markers in breast cancer.The exposure of breast cancer cells to fulvestrant and tamoxifen modulates cell migration differently.Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†.Skeletal and Uterotrophic Effects of Endoxifen in Female Rats.A computational based approach to identify estrogen receptor alpha/beta heterodimer selective ligands.Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark
P2860
Q26739969-8F1574A1-799C-4EC6-9386-223543542FE0Q28480546-51ADF837-8493-44CE-BB94-52E5862EB61AQ28539057-1E61D217-0EAA-497C-910E-0A8DDEEEFFB0Q28603633-6A27720F-768C-4EB8-AE60-BDDB90203218Q32185870-EB39FA1B-24C0-413E-A862-8C0CBD9D0CAAQ33856461-AB68312A-8737-4B40-98A2-F1DD1F57AA4AQ34216817-C8EFBA45-C15A-4DAB-B749-36FE50B7FFF9Q34253146-A1787165-7060-4606-A437-727B08DFDCC7Q34334131-3D0DFEEC-13F1-457A-8EA4-387A94B40330Q34736986-D5905A8D-74A7-49C9-9309-3DC32FB0C30AQ34991926-6F1441DF-618D-460A-99FA-6438737DCD38Q35058455-A41CF7AF-C34B-4077-AFF7-E37E604FF261Q35168556-2C1C8781-5DC0-4F7A-BBBA-2C9545ED2087Q35510803-E5FCD214-034F-4972-B32B-5C16732A1B78Q35869243-DD63D634-61A5-4FA0-8036-7E6224F8D3CAQ35973424-7105117E-9AE3-41D4-84C8-558867CF08CEQ36248899-C8AB8ED9-F217-4EA1-ADB8-18277D27C30BQ36822938-BAD15418-92FC-47B9-9EBA-441A3410F5C1Q37049590-7B7AD1BB-831E-4586-9DF3-CE64DC027FFCQ37353645-613EE33E-2C26-4C36-B067-69859E9DEBE2Q37382513-88F98680-A679-478B-B846-37530658F9CFQ37624907-8C6296E7-84E4-4F37-A6C7-DC7AA8DFD0C4Q38028797-2C4188D7-5CE9-466C-A536-2BD18C9B415DQ38598704-DF6DB78C-511F-46C9-A193-DAF220E775EEQ39111584-98F03B81-6106-46D0-9F5F-8FF27002D27BQ41273764-214CA37E-FAE2-4F7C-AEAC-BFEA1BD7C2A4Q41721517-66386DF0-EDCA-4440-B61F-3369A98C46E1Q47620125-0A704F8B-EFB6-4A92-ACA5-5419EA2E2863Q49359257-464E0450-3112-46C2-B3DE-514070F8819BQ57108405-0E2CEEBD-0E28-4A9A-A50F-458B17B7BCAE
P2860
Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Estrogen receptor-beta sensiti ...... strogenic actions of endoxifen
@ast
Estrogen receptor-beta sensiti ...... strogenic actions of endoxifen
@en
type
label
Estrogen receptor-beta sensiti ...... strogenic actions of endoxifen
@ast
Estrogen receptor-beta sensiti ...... strogenic actions of endoxifen
@en
prefLabel
Estrogen receptor-beta sensiti ...... strogenic actions of endoxifen
@ast
Estrogen receptor-beta sensiti ...... strogenic actions of endoxifen
@en
P2093
P2860
P356
P1476
Estrogen receptor-beta sensiti ...... strogenic actions of endoxifen
@en
P2093
James N Ingle
John R Hawse
Malayannan Subramaniam
Matthew P Goetz
Sarah B Grygo
Thomas C Spelsberg
Vivian Negron
Wilma L Lingle
Xianglin Wu
P2860
P2888
P356
10.1186/BCR2844
P50
P577
2011-03-10T00:00:00Z
P5875
P6179
1038681652